Literature DB >> 30191563

Bone marrow harvest in donors with anaemia.

Krzysztof Bartnik1, Katarzyna Pruszczyk1, Kamila Skwierawska1, Małgorzata Król1, Milena Płachta1, Albert Moskowicz1, Tomasz Zakrzewski1, Elżbieta Urbanowska1, Wiesław Wiktor Jędrzejczak1, Emilian Snarski1.   

Abstract

BACKGROUND: Bone marrow harvest (BMH) for haematopoietic stem cell transplantation is a well-established procedure. The guidelines of World Marrow Donor Association provide information on donor selection. However, some of the guidelines regarding donors with anaemia prior to harvest lack in supporting data from clinical studies. With this study, we aimed to provide such data.
MATERIAL AND METHODS: In this retrospective, single-centre study, we analysed the interplay between haemoglobin levels and BMH and BMH impact on haemoglobin levels in a cohort of 149 unrelated BM donors, including 13 subjects with mild anaemia.
RESULTS: The BMH led to significantly lower decrease in haemoglobin levels in donors with anaemia than in control group (1·79 g/dl vs. 2·56 g/dl, P < 0·0001). The following parameters: BMH volume (ml), BMH volume/donor body weight (ml/kg), total nucleated cells (TNC) in product (×108 ) and TNC/kg recipient body weight in product (×108 /kg) did not differ significantly between those two analysed groups (P > 0·05). Median BM volume harvested from anaemic donors was 16·34 ml/kg; none of them required blood transfusion after BMH.
CONCLUSION: Mild anaemia prior to BMH does not significantly impact the collection results. The BMH is safe and feasible in donors with mild anaemia.
© 2018 International Society of Blood Transfusion.

Entities:  

Keywords:  anaemia prior to procedure; unrelated donors

Mesh:

Substances:

Year:  2018        PMID: 30191563     DOI: 10.1111/vox.12709

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  1 in total

1.  Should We Stop Collecting the Preoperative Autologous Blood before Bone Marrow Harvest?

Authors:  Daniel Lysák; Lenka Hejretová; Marcela Hrabětová; Pavel Jindra
Journal:  J Clin Med       Date:  2021-05-14       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.